Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

597 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic factors and risk groups in T1G3 non-muscle-invasive bladder cancer patients initially treated with Bacillus Calmette-Guérin: results of a retrospective multicenter study of 2451 patients.
Gontero P, Sylvester R, Pisano F, Joniau S, Vander Eeckt K, Serretta V, Larré S, Di Stasi S, Van Rhijn B, Witjes AJ, Grotenhuis AJ, Kiemeney LA, Colombo R, Briganti A, Babjuk M, Malmström PU, Oderda M, Irani J, Malats N, Baniel J, Mano R, Cai T, Cha EK, Ardelt P, Varkarakis J, Bartoletti R, Spahn M, Johansson R, Frea B, Soukup V, Xylinas E, Dalbagni G, Karnes RJ, Shariat SF, Palou J. Gontero P, et al. Among authors: johansson r. Eur Urol. 2015 Jan;67(1):74-82. doi: 10.1016/j.eururo.2014.06.040. Epub 2014 Jul 16. Eur Urol. 2015. PMID: 25043942 Free article.
Bacillus Calmette-Guérin is superior to a combination of epirubicin and interferon-alpha2b in the intravesical treatment of patients with stage T1 urinary bladder cancer. A prospective, randomized, Nordic study.
Duchek M, Johansson R, Jahnson S, Mestad O, Hellström P, Hellsten S, Malmström PU; Members of the Urothelial Cancer Group of the Nordic Association of Urology. Duchek M, et al. Among authors: johansson r. Eur Urol. 2010 Jan;57(1):25-31. doi: 10.1016/j.eururo.2009.09.038. Epub 2009 Oct 6. Eur Urol. 2010. PMID: 19819617 Clinical Trial.
5-Year outcome of a randomized prospective study comparing bacillus Calmette-Guérin with epirubicin and interferon-α2b in patients with T1 bladder cancer.
Hemdan T, Johansson R, Jahnson S, Hellström P, Tasdemir I, Malmström PU; Members of the Urothelial Cancer Group of the Nordic Association of Urology. Hemdan T, et al. Among authors: johansson r. J Urol. 2014 May;191(5):1244-9. doi: 10.1016/j.juro.2013.11.005. Epub 2013 Nov 11. J Urol. 2014. PMID: 24231843 Clinical Trial.
Improving the Specificity of Screening for Lethal Prostate Cancer Using Prostate-specific Antigen and a Panel of Kallikrein Markers: A Nested Case-Control Study.
Stattin P, Vickers AJ, Sjoberg DD, Johansson R, Granfors T, Johansson M, Pettersson K, Scardino PT, Hallmans G, Lilja H. Stattin P, et al. Among authors: johansson m, johansson r. Eur Urol. 2015 Aug;68(2):207-13. doi: 10.1016/j.eururo.2015.01.009. Epub 2015 Feb 11. Eur Urol. 2015. PMID: 25682340 Free PMC article.
The Swedish rectal cancer registry.
Påhlman L, Bohe M, Cedermark B, Dahlberg M, Lindmark G, Sjödahl R, Ojerskog B, Damber L, Johansson R. Påhlman L, et al. Among authors: johansson r. Br J Surg. 2007 Oct;94(10):1285-92. doi: 10.1002/bjs.5679. Br J Surg. 2007. PMID: 17661309
Reply by Authors.
Vertosick EA, Häggström C, Sjoberg DD, Hallmans G, Johansson R, Vickers AJ, Stattin P, Lilja H. Vertosick EA, et al. Among authors: johansson r. J Urol. 2020 Aug;204(2):287-288. doi: 10.1097/JU.0000000000001007.02. Epub 2020 May 20. J Urol. 2020. PMID: 32432507 No abstract available.
597 results